There have been clinical studies reporting newly diagnosed cases of cerebral sinus vein thrombosis in patients with MTHFR mutations following injection of the vector-based ChAdOx1 COVID-19 vaccine (Fousse et al., 2022). This evidence concerns the gene MTHFR and COVID-19.